The activation of TLR2 leads to the release of pro‐inflammatory cytokines such as IL‐6 and TNF‐α, which can help suppress CDI symptoms and prevent both the initial occurrence and recurrence of the infection [60]. The gene discussed is TNF; the disease is infection.